CP-226,269
CP-226,269 je lek koji deluje kao dopaminski agonist. On je selektivan za D4 podtip. CP-226,269 se koristi za istraživanje uloge D4 receptora u mozgu.[1][2]
IUPAC ime | |
---|---|
5-fluoro-2-[(4-piridin-2-ilpiperazin-1-il)metil]-1H-indol | |
Identifikatori | |
CAS broj | 220941-93-5 |
ATC kod | none |
PubChem | CID 9796720 |
ChemSpider | 7972486 |
ChEMBL | CHEMBL77395 |
Hemijski podaci | |
Formula | C18H19FN4 |
Molarna masa | 310,368 g/mol |
| |
|
Reference
уреди- ^ Sharma A, Kramer ML, Wick PF, Liu D, Chari S, Shim S, Tan W, Ouellette D, Nagata M, DuRand CJ, Kotb M, Deth RC (1999). „D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia”. Molecular Psychiatry. 4 (3): 235—46. PMID 10395213. doi:10.1038/sj.mp.4000522.
- ^ Basso AM, Gallagher KB, Bratcher NA, Brioni JD, Moreland RB, Hsieh GC, Drescher K, Fox GB, Decker MW, Rueter LE (2005). „Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test”. Neuropsychopharmacology. 30 (7): 1257—68. PMID 15688083. doi:10.1038/sj.npp.1300677.